Ensuring accessible and affordable cancer care remains a critical public health objective in India. A recent parliamentary panel has put forth significant recommendations aimed at transforming cancer diagnosis and treatment accessibility across the nation. This comprehensive report highlights the urgent need for policy-level interventions, fostering wider inclusion and reducing the financial burden on patients. Indeed, the cost of cancer treatment often exceeds the annual income for a large percentage of the Indian population, underscoring the necessity for these reforms. [16]
Standardizing Cancer Diagnostics and Drug Pricing
The parliamentary panel strongly advocates for developing cancer diagnostic packages with standardized pricing. These packages should operate under government-regulated health insurance schemes to promote broader inclusion. Additionally, the Committee recommends expanding the price caps enforced by the National Pharmaceutical Pricing Authority (NPPA). Currently, a 30 percent trade margin cap exists on 42 essential anti-cancer drugs. Extending this cap to include cancer vaccines, immunotherapy, and oral chemotherapy is crucial. This expansion of regulatory oversight is vital for containing insurer costs, ultimately making cancer insurance products more affordable and accessible for a wider population. [19]
Enhancing Cancer Care Infrastructure and Access
Building more cancer hospitals equipped with advanced medical technology is another key recommendation. The panel suggests a combination of government funding, private sector participation, and Public-Private Partnership (PPP) models for establishing these facilities. Furthermore, these hospitals must be empanelled within insurer networks to facilitate cashless services for patients. Clearly defined treatment packages will assist insurers in standardizing costs, passing on financial benefits to policyholders. Recognizing significant geographical disparities, especially the concentration of cancer centers in urban areas, the committee also pressed for establishing dedicated cancer screening centers. [2, 5, 11, 19]
Integrating Screening into Major Health Schemes
Early detection plays a pivotal role in improving cancer outcomes. Therefore, the Committee recommends integrating cancer screening within major health schemes such as PMJAY (Pradhan Mantri Jan Arogya Yojana). Including cancer diagnostic tests under CGHS (Central Government Health Scheme) and ECHS (Ex-Servicemen Contributory Health Scheme) is also advised. This strategy enables optimal utilization of private sector diagnostic infrastructure for public health objectives. Low rates of cancer screening in India highlight a critical area for improvement. [16, 19]
Fostering Partnerships and Public Awareness for Affordable Cancer Care
Ensuring affordable cancer care requires a multi-stakeholder approach. The Committee emphasized the critical need for effective public-private partnerships, standardized treatment protocols, and expanded insurance coverage. These measures aim to alleviate the financial burden on patients. Strengthening healthcare infrastructure and enhancing public awareness are integral to a resilient cancer care ecosystem. To bridge existing service delivery and affordability gaps, the Committee recommended greater participation from insurance providers, banking institutions, and Corporate Social Responsibility (CSR) initiatives. This coordinated engagement is pivotal for creating an inclusive, sustainable, and patient-centric cancer care framework. [19]
The panel also observed an inadequacy in the number of diagnostic centers, particularly in rural and underserved regions. Establishing additional diagnostic centers, especially in these areas, is crucial. Their availability at regulated package rates will facilitate their inclusion in insurer networks, extending cashless treatment to more beneficiaries. Furthermore, the government should scale up national screening programs, focusing on regions with limited medical access. Intensifying region-specific awareness campaigns, with active involvement from non-government organizations (NGOs), will ensure maximum outreach. Leveraging celebrity cancer survivors can also effectively convey preventive messages, helping to overcome social stigma. [9, 11, 19]
Patient Assistance Programmes (PAPs) are commendable initiatives that ensure access to affordable medicines, especially for economically vulnerable sections. Programs like the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) significantly provide low-cost medicines. While some pharmaceutical firms offer patient support programs, their presence remains limited. The panel recommended engaging more pharmaceutical manufacturers in such initiatives, especially where healthcare access is inadequate. PAPs should also educate patients about treatment methodologies and adherence, as well as inform them about various government schemes. [1, 8, 12, 13, 14, 15]
Frequently Asked Questions
Q1: What are the main recommendations of the parliamentary panel for cancer care in India?
The panel recommends standardized pricing for cancer diagnostic packages, extended NPPA price caps to more anti-cancer therapies, establishment of more cancer hospitals via PPP models, and integration of cancer screening into major health schemes like PMJAY, CGHS, and ECHS. [19]
Q2: How does the panel propose to make cancer insurance more affordable?
By extending NPPA price caps to cover cancer vaccines, immunotherapy, and oral chemotherapy, insurer costs will be contained. Furthermore, standardizing diagnostic and treatment packages helps insurers streamline costs, passing benefits to policyholders. [19]
Q3: What role do public-private partnerships play in improving cancer care?
Public-private partnerships are crucial for establishing more cancer hospitals and diagnostic centers, particularly in underserved areas. This collaboration helps expand infrastructure and facilitates cashless services within insurer networks, enhancing accessibility and affordability. [19]
References
- Parliamentary panel bats for affordable cancer insurance – ETHealthworld.
- Cancer Care Delivery Challenges in India during the COVID-19 Era: Are We Prepared for the Postpandemic Shock?
- National Pharmaceutical Pricing Authority directs firms to cut prices of three anti-cancer drugs – The Hindu.
- NPPA asks companies to cut prices of three cancer drugs post tax relief.
- State of Cancer Care in India and Opportunities for Innovation.
- NPPA asks pharma manufacturers to cut price of 3 anti-cancer drugs – Business Standard.
- National Pharmaceutical Pricing Authority may cap cancer drug prices via Para 10.
- Government Schemes for Cancer Treatment | Schemes by Central & State Governments | CancerAssist.
- Unique Challenges of Cancer Care in India – The ASCO Post.
- List of Government Health Schemes for Cancer Patients in Maharashtra – 1mg.
- Redefining Cancer Care: Trends, Challenges, and Breakthroughs in the Indian Context.
- National Pharmaceutical Pricing Authority fixes ceiling prices of 131 scheduled anticancer formulations: Centre – ET Government.
- Towards a Cancer-Free India – PIB.
- Financial Aid for Cancer Treatment – YouWeCan.
- About Us-WORLD CANCER CARE CHARITABLE SOCIETY.
- India’s Cancer Crisis: Affordable Care – EY.
- Eligibility & Documents Required For Buying Cancer Insurance – IFFCO-Tokio.
- Cancer Insurance Plan – Key Factors to Choose the Best Coverage – Star Health Insurance.
- Parliamentary panel seeks standardised Cancer diagnostic packages under govt insurance.
- Cancer Insurance Policies in India: Everything You Need to Know – New – CarePal Secure.
- 5 Best Cancer Insurance Plans in India 2025 – PolicyX.
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.